InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
ctine2020 Free
10/27/10 2:31 PM
profile icon
Tanail Free
07/06/05 10:27 PM
profile icon
Tanail Free
05/12/05 9:25 AM
profile icon
Tanail Free
05/12/05 9:24 AM
profile icon
Tanail Free
04/27/05 11:44 PM
profile icon
Tanail Free
03/30/05 6:52 PM
profile icon
Tanail Free
03/06/05 5:58 PM
profile icon
Tanail Free
02/20/05 11:06 PM
profile icon
Tanail Free
02/16/05 10:44 PM
profile icon
Tanail Free
02/16/05 10:42 PM
profile icon
Tanail Free
02/16/05 10:39 PM
profile icon
Tanail Free
02/16/05 10:38 PM
profile icon
Tanail Free
02/16/05 10:04 PM
profile icon
cashwealth Free
01/29/05 10:51 AM

looks promissing (pbotf) RSS Feed

Followers
0
Posters
3
Posts (Today)
0
Posts (Total)
15
Created
01/28/05
Type
Free
Moderators
aREPEAT/Penn Biotech Announces Traffic ITS Progress TUESDAY, OCTOBER 19, 2004 7:00 AM - BusinessWire PBOTF 0.17 +0.011 Enter Symbol: Enter Keyword: VANCOUVER, British Columbia, Oct 19, 2004 (BUSINESS WIRE) -- The Board of Directors of Penn Biotech Inc (PBOTF) is pleased to advise that its renewed license agreement with Traffic ITS Co Ltd. has been signed and approved by both parties. Traffic reported total revenues in excess of US$30 million in calendar year 2003. PBI also announces that it has formed a new wholly-owned subsidiary, Western ITS Ltd., with the mandate for the Intelligent Transportation System ("ITS") business in China and North America. Western ITS is vigorously pursuing business opportunities in the People's Republic of China. In order to be eligible to submit bids on ITS projects, companies must demonstrate bonding capability. To this end, the Company has commenced negotiations with a financial partner who will provide such bonding and project financing capability for all Chinese ITS projects over US$10 million. As has been stated previously, according to ITS of America, the US ITS trade Association, expenditure in the traffic infrastructure market in China is forecast to be in excess of US$30 billion per year for the next several years. Beijing alone is expected to spend approximately US$10.8 billion in the lead up to the 2008 Olympic games. PBI Agriculture PBI also wishes to clarify some information in its news release dated October 18 2004. As stated in that release, the company has signed a joint venture agreement with the Chinese Ministry of Agriculture to grow seed potatoes for the growing potato processing industry in China. The initial planting will be for a total of 2,000 acres, growing to 48,000 acres by 2010. Crop yields vary, but at the low end of the expected range of ten tons per acre, this would provide 20,000 tons initially, growing to 480,000 tons by 2010. PBI and the ministry will share costs and profits from the sale of the potatoes on a 50/50 basis, with a gross sale price forecast at US$130 per ton. Thus, total revenues associated with the project are expected to range from an initial US$2.6 million to US$62.4 million. PBI's seed potato growing technology provides a significant advantage to other technologies used in the propagation of seed potatoes. It is the only technology which mass produces consistently high quality, pathogen free minitubers which meet all the quality requirements for potato processors. Statements in this news release that are not historical facts, including statements about plans and expectations regarding products and opportunities, demand and acceptance of new or existing products, capital resources and future financial results are forward-looking. Forward-looking statements involve risks and uncertainties which may cause the Company's actual results in future periods to differ materially from those expressed. These uncertainties and risks include changing consumer preferences, lack of success of new products, loss of the Company's customers, competition and other factors discussed from time to time in the Company's filings with the Securities & Exchange Commission. No securities regulatory authority has approved or disapproved of this news release. SOURCE: Penn Biotech Inc. Penn Biotech Inc.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
pbotf Latest News
  • No Recent News Available for this company!
New Post